PD‐L1 in gestational trophoblastic disease: an antibody evaluation
Sign Up to like & getrecommendations! Published in 2022 at "Acta Obstetricia et Gynecologica Scandinavica"
DOI: 10.1111/aogs.14404
Abstract: Treatment with antibodies directed against programed‐cell death ligand 1 (PD‐L1) is a novel therapy for patients with gestational trophoblastic disease. Assessment of PD‐L1 expression in tumor tissue is commonly used to identify patients who might… read more here.
Keywords: trophoblastic disease; gestational trophoblastic; antibody evaluation; disease antibody ... See more keywords